Stay Up to Date
with SHINE

SHINE Medical Technologies LLC, today announced that it is holding its second annual design competition in collaboration with the School District of Janesville. The competition asks students to create a 3D-printed object to be used by SHINE as an employee award of excellence, titled The Illuminator Award.

Founder and CEO Greg Piefer has received the University of Wisconsin-Madison Department of Physics’ 2019 Distinguished Alumni Award. The award is the highest honor presented to accomplished graduates of UW-Madison for their professional achievements, contributions to society and support of the university.

SHINE today announced that its team for the annual Bert Blain Memorial Heart Walk in Janesville last weekend exceeded its fundraising goal by 40 percent.

SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors.

SHINE today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI. SHINE broke ground on the facility in May of this year.

SHINE and Phoenix tested the first production-ready accelerator in SHINE’s Janesville facility over the course of 5.5 days to determine percentage uptime and total neutron output.

SHINE Medical Technologies and Institute of Organic Chemistry and Biochemistry of the CAS have entered into an intellectual property license agreement providing SHINE with a global, exclusive license to a novel method for separating rare earth elements.

SHINE held a groundbreaking ceremony today to celebrate the start of construction of its US medical isotope production facility in Janesville, Wisconsin.

SHINE Takes Next Step Toward Production of Life-Saving Medical Isotopes. City of Janesville Transfers 91 Acres to SHINE for Medical Isotope Facility.

SHINE Medical Technologies and Deerfield Management Company, a healthcare investment firm, announced today the closing of a definitive agreement providing a $150 million financing commitment to support diagnostic and therapeutic medical isotope manufacturing.

SHINE announced today that Phoenix has delivered the first production accelerator to SHINE’s Building One, the first building on the SHINE medical isotope production campus in Janesville, WI.

SHINE announced today that it is holding a design competition in collaboration with the Janesville School District. The competition asks students to create a 3D-printed object to be used by SHINE as an employee award of excellence, titled The Illuminator Award.

SHINE raised more than double its fundraising goal, and this year is proud to have exceeded its goal for the second year in a row, raising $4,333.

SHINE was recently featured in ANS Nuclear News article about how we will soon be creating a stable supply of molybdenum-99.